Recent Advances in the Pathogenesis of Pancreatic Endocrine Neoplasms

作者: Omie Mills , Nelly A. Nasir , Jonathan R. Strosberg , Larry K. Kvols , Domenico Coppola

DOI: 10.1007/978-90-481-3725-1_17

关键词:

摘要: Evidence is rapidly accumulating to allow construction of a working hypothesis the pathogenesis PENs. Many studies have contributed significantly our current understanding PEN tumorigenesis and progression. We learned, mainly through study β-cell regulation, that neogenesis transdifferentiation, replication, hypertrophy, apoptosis work together control endocrine cell mass. However, pluripotent stem cells thought play role in transdifferentiation aree yet be discovered. Studies found many same mechanisms operate during pancreatic development embryo, also regulate mass adults. One could imagine how deregulation these processes lead oncogenesis. All are steered by regulators such as glucose, c-Myc, P13K-AKT/PKB, PDX-1, Ngn-3, others. members complex molecular pathways been implicated Genetic syndromes, which include PENs one their components, for identification genes associated with genesis PENs, including MEN1 gene, vHL NF-1 TSC1 TSC2 genes. Advanced testing, currently making it more feasible pursue newer lines genetic unravel an increasing number chromosomal aberrations Multiple alterations, involving migratory, cycle, angiogenic functions, promote development, growth, invasion, metastases. As result studies, phase III trials novel therapies targeting mTOR, VEGF other targets progress. Focused investigation various mediators/mechanisms will contribute diagnostic, therapeutic, preventive stratagies, well facilitate prognostic predictive markers, while continuing advance

参考文章(287)
H Kronenberg, J Ruderman, T Bloom, C Rosenberg, T Motokura, A Arnold, H G Kim, A Bale, M Brown, PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13. Henry Ford Hospital medical journal. ,vol. 40, pp. 177- 180 ,(1992)
R Hennig, XZ Ding, Thomas E Adrian, None, On the role of the islets of Langerhans in pancreatic cancer Histology and Histopathology. ,vol. 19, pp. 999- 1011 ,(2004) , 10.14670/HH-19.999
E. Verhoeven, R. J. A. M. Michalides, W. J. Mooi, E. Schuuring, Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. ,vol. 7, pp. 355- 361 ,(1992)
M C Skarulis, Y S Kim, A L Burns, L A James, C Heppner, S Y Park, S C Chandrasekharappa, M R Emmert-Buck, L A Liotta, L V Debelenko, I A Lubensky, M R Erdos, J Crabtree, S K Saggar, P Manickam, P K Goldsmith, F S Collins, S J Marx, Z Zhuang, M B Kester, A M Spiegel, S K Agarwal, S C Guru, Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Progress in Hormone Research. ,vol. 54, pp. 397- 439 ,(1999)
DANLING GU, NORA SARVETNICK, A transgenic model for studying islet development. Recent Progress in Hormone Research. ,vol. 49, pp. 161- 165 ,(1994) , 10.1016/B978-0-12-571149-4.50012-X
D.K. Sandsmark, David. H. Gutmann, C. Pelletier, J.D. Weber, Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histology and Histopathology. ,vol. 22, pp. 895- 903 ,(2007) , 10.14670/HH-22.895
Peter H. Maxwell, C. W. Pugh, P. J. Ratcliffe, The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Advances in Experimental Medicine and Biology. ,vol. 502, pp. 365- 376 ,(2001) , 10.1007/978-1-4757-3401-0_24
H Valentin, S Huet, A M Prieur, B Caillou, A Bernard, H Groux, CD44 contributes to T cell activation. Journal of Immunology. ,vol. 143, pp. 798- 801 ,(1989)
Immo E. Scheffler, Molecular Genetics of Succinate:Quinone Oxidoreductase in Eukaryotes Progress in Nucleic Acid Research and Molecular Biology. ,vol. 60, pp. 267- 315 ,(1998) , 10.1016/S0079-6603(08)60895-8
Stacey E Mills, Darryl Carter, Joel K Greenson, Victor E Reuter, Mark H Stoler, Sternberg's Diagnostic Surgical Pathology ,(2012)